Circular RNAs in endometrial carcinoma (Review)
- Authors:
- Shan Gao
- Tianjun Zhao
- Fangchi Meng
- Yinzhou Luo
- Yan Li
- Yong Wang
-
Affiliations: Department of Obstetrics and Gynecology, Central Hospital Affiliated to Shenyang Medical College, Shenyang, Liaoning 110024, P.R. China, Fourth Department of Orthopedic Surgery, Central Hospital Affiliated to Shenyang Medical College, Shenyang, Liaoning 110024, P.R. China, Department of Orthopedic Surgery, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China - Published online on: October 19, 2022 https://doi.org/10.3892/or.2022.8427
- Article Number: 212
-
Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Bell DW and Ellenson LH: Molecular genetics of endometrial carcinoma. Annu Rev Pathol. 14:339–367. 2019. View Article : Google Scholar : PubMed/NCBI | |
Jiang X, Tang H and Chen T: Epidemiology of gynecologic cancers in China. J Gynecol Oncol. 29:e72018. View Article : Google Scholar : PubMed/NCBI | |
Brooks RA, Fleming GF, Lastra RR, Lee NK, Moroney JW, Son CH, Tatebe K and Veneris JL: Current recommendations and recent progress in endometrial cancer. CA Cancer J Clin. 69:258–279. 2019.PubMed/NCBI | |
Pecorelli S: Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI | |
Lee YC, Lheureux S and Oza AM: Treatment strategies for endometrial cancer: Current practice and perspective. Curr Opin Obstet Gynecol. 29:47–58. 2017. View Article : Google Scholar : PubMed/NCBI | |
Sonoda Y: Surgical treatment for apparent early stage endometrial cancer. Obstet Gynecol Sci. 57:1–10. 2014. View Article : Google Scholar : PubMed/NCBI | |
Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, Marth C, Nout R, Querleu D, Mirza MR, et al: ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. Ann Oncol. 27:16–41. 2016. View Article : Google Scholar : PubMed/NCBI | |
Aoki Y, Kanao H, Wang X, Yunokawa M, Omatsu K, Fusegi A and Takeshima N: Adjuvant treatment of endometrial cancer today. Jpn J Clin Oncol. 50:753–765. 2020. View Article : Google Scholar : PubMed/NCBI | |
Chen LL and Yang L: Regulation of circRNA biogenesis. RNA Biol. 12:381–388. 2015. View Article : Google Scholar : PubMed/NCBI | |
Suzuki H and Tsukahara T: A view of pre-mRNA splicing from RNase R resistant RNAs. Int J Mol Sci. 15:9331–9342. 2014. View Article : Google Scholar : PubMed/NCBI | |
Lu Q, Liu T, Feng H, Yang R, Zhao X, Chen W, Jiang B, Qin H, Guo X, Liu M, et al: Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN. Mol Cancer. 18:1112019. View Article : Google Scholar : PubMed/NCBI | |
Chen RX, Chen X, Xia LP, Zhang JX, Pan ZZ, Ma XD, Han K, Chen JW, Judde JG, Deas O, et al: N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nat Commun. 10:46952019. View Article : Google Scholar : PubMed/NCBI | |
Liang G, Ling Y, Mehrpour M, Saw PE, Liu Z, Tan W, Tian Z, Zhong W, Lin W, Luo Q, et al: Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression. Mol Cancer. 19:652020. View Article : Google Scholar : PubMed/NCBI | |
Li B, Zhu L, Lu C, Wang C, Wang H, Jin H, Ma X, Cheng Z, Yu C, Wang S, et al: circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat Commun. 12:2952021. View Article : Google Scholar : PubMed/NCBI | |
Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma JZ, Sun SH, Yang F and Zhou WP: Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 68:1214–1227. 2018. View Article : Google Scholar : PubMed/NCBI | |
Rong Z, Xu J, Shi S, Tan Z, Meng Q, Hua J, Liu J, Zhang B, Wang W, Yu X and Liang C: Circular RNA in pancreatic cancer: A novel avenue for the roles of diagnosis and treatment. Theranostics. 11:2755–2769. 2021. View Article : Google Scholar : PubMed/NCBI | |
Zheng Q, Bao C, Guo W, Li S, Chen J, Chen B, Luo Y, Lyu D, Li Y, Shi G, et al: Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun. 7:112152016. View Article : Google Scholar : PubMed/NCBI | |
You X, Vlatkovic I, Babic A, Will T, Epstein I, Tushev G, Akbalik G, Wang M, Glock C, Quedenau C, et al: Neural circular RNAs are derived from synaptic genes and regulated by development and plasticity. Nat Neurosci. 18:603–610. 2015. View Article : Google Scholar : PubMed/NCBI | |
Ashwal-Fluss R, Meyer M, Pamudurti NR, Ivanov A, Bartok O, Hanan M, Evantal N, Memczak S, Rajewsky N and Kadener S: circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 56:55–66. 2014. View Article : Google Scholar : PubMed/NCBI | |
Sun X, Wang L, Ding J, Wang Y, Wang J, Zhang X, Che Y, Liu Z, Zhang X, Ye J, et al: Integrative analysis of Arabidopsis thaliana transcriptomics reveals intuitive splicing mechanism for circular RNA. FEBS Lett. 590:3510–3516. 2016. View Article : Google Scholar : PubMed/NCBI | |
Lyu D and Huang S: The emerging role and clinical implication of human exonic circular RNA. RNA Biol. 14:1000–1006. 2017. View Article : Google Scholar : PubMed/NCBI | |
Liang D and Wilusz JE: Short intronic repeat sequences facilitate circular RNA production. Genes Dev. 28:2233–2247. 2014. View Article : Google Scholar : PubMed/NCBI | |
Zhang XO, Wang HB, Zhang Y, Lu X, Chen LL and Yang L: Complementary sequence-mediated exon circularization. Cell. 159:134–147. 2014. View Article : Google Scholar : PubMed/NCBI | |
Wang F, Nazarali AJ and Ji S: Circular RNAs as potential biomarkers for cancer diagnosis and therapy. Am J Cancer Res. 6:1167–1176. 2016.PubMed/NCBI | |
Chen LL: The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 21:475–490. 2020. View Article : Google Scholar : PubMed/NCBI | |
Conn SJ, Pillman KA, Toubia J, Conn VM, Salmanidis M, Phillips CA, Roslan S, Schreiber AW, Gregory PA and Goodall GJ: The RNA binding protein quaking regulates formation of circRNAs. Cell. 160:1125–1134. 2015. View Article : Google Scholar : PubMed/NCBI | |
Lasda E and Parker R: Circular RNAs co-precipitate with extracellular vesicles: A possible mechanism for circRNA clearance. PLoS One. 11:e01484072016. View Article : Google Scholar : PubMed/NCBI | |
Liu Y, Chen S, Zong ZH, Guan X and Zhao Y: CircRNA WHSC1 targets the miR-646/NPM1 pathway to promote the development of endometrial cancer. J Cell Mol Med. 24:6898–6907. 2020. View Article : Google Scholar : PubMed/NCBI | |
Hu J, Peng X, Du W, Huang Y, Zhang C and Zhang X: circSLC6A6 sponges miR-497-5p to promote endometrial cancer progression via the PI4KB/hedgehog axis. J Immunol Res. 2021:55123912021. View Article : Google Scholar : PubMed/NCBI | |
Liu Y, Yuan H and He T: Downregulated circular RNA hsa_circ_0005797 inhibits endometrial cancer by modulating microRNA-298/catenin delta 1 signaling. Bioengineered. 13:4634–4645. 2022. View Article : Google Scholar : PubMed/NCBI | |
Mitra A, Pfeifer K and Park KS: Circular RNAs and competing endogenous RNA (ceRNA) networks. Transl Cancer Res. 7 (Suppl 5):S624–S628. 2018. View Article : Google Scholar : PubMed/NCBI | |
Quévillon Huberdeau M and Simard MJ: A guide to microRNA-mediated gene silencing. FEBS J. 286:642–652. 2019. View Article : Google Scholar : PubMed/NCBI | |
Yates LA, Norbury CJ and Gilbert RJ: The long and short of microRNA. Cell. 153:516–519. 2013. View Article : Google Scholar : PubMed/NCBI | |
Zhu L, Deng H, Hu J, Huang S, Xiong J and Deng J: The promising role of miR-296 in human cancer. Pathol Res Pract. 214:1915–1922. 2018. View Article : Google Scholar : PubMed/NCBI | |
Huang X, Zhu X, Yu Y, Zhu W, Jin L, Zhang X, Li S, Zou P, Xie C and Cui R: Dissecting miRNA signature in colorectal cancer progression and metastasis. Cancer Lett. 501:66–82. 2021. View Article : Google Scholar : PubMed/NCBI | |
Padma VV: An overview of targeted cancer therapy. Biomedicine (Taipei). 5:192015. View Article : Google Scholar : PubMed/NCBI | |
Shariati M and Meric-Bernstam F: Targeting AKT for cancer therapy. Expert Opin Investig Drugs. 28:977–988. 2019. View Article : Google Scholar : PubMed/NCBI | |
Moody TW, Lee L, Ramos-Alvarez I, Iordanskaia T, Mantey SA and Jensen RT: Bombesin receptor family activation and CNS/neural tumors: Review of evidence supporting possible role for novel targeted therapy. Front Endocrinol (Lausanne). 12:7280882021. View Article : Google Scholar : PubMed/NCBI | |
Kristensen LS, Jakobsen T, Hager H and Kjems J: The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol. 19:188–206. 2022. View Article : Google Scholar : PubMed/NCBI | |
Panda AC: Circular RNAs Act as miRNA sponges. Adv Exp Med Biol. 1087:67–79. 2018. View Article : Google Scholar : PubMed/NCBI | |
Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, Maier L, Mackowiak SD, Gregersen LH, Munschauer M, et al: Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 495:333–338. 2013. View Article : Google Scholar : PubMed/NCBI | |
Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function as efficient microRNA sponges. Nature. 495:384–388. 2013. View Article : Google Scholar : PubMed/NCBI | |
Su M, Xiao Y, Ma J, Tang Y, Tian B, Zhang Y, Li X, Wu Z, Yang D, Zhou Y, et al: Circular RNAs in cancer: Emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers. Mol Cancer. 18:902019. View Article : Google Scholar : PubMed/NCBI | |
Zang J, Lu D and Xu A: The interaction of circRNAs and RNA binding proteins: An important part of circRNA maintenance and function. J Neurosci Res. 98:87–97. 2020. View Article : Google Scholar : PubMed/NCBI | |
Kristensen LS, Hansen TB, Venø MT and Kjems J: Circular RNAs in cancer: Opportunities and challenges in the field. Oncogene. 37:555–565. 2018. View Article : Google Scholar : PubMed/NCBI | |
Wang Y, Mo Y, Gong Z, Yang X, Yang M, Zhang S, Xiong F, Xiang B, Zhou M, Liao Q, et al: Circular RNAs in human cancer. Mol Cancer. 16:252017. View Article : Google Scholar : PubMed/NCBI | |
Dong W, Bi J, Liu H, Yan D, He Q, Zhou Q, Wang Q, Xie R, Su Y, Yang M, et al: Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axis. Mol Cancer. 18:952019. View Article : Google Scholar : PubMed/NCBI | |
Zhu Z, Rong Z, Luo Z, Yu Z, Zhang J, Qiu Z and Huang C: Circular RNA circNHSL1 promotes gastric cancer progression through the miR-1306-3p/SIX1/vimentin axis. Mol Cancer. 18:1262019. View Article : Google Scholar : PubMed/NCBI | |
Weingarten-Gabbay S, Elias-Kirma S, Nir R, Gritsenko AA, Stern-Ginossar N, Yakhini Z, Weinberger A and Segal E: Comparative genetics. Systematic discovery of cap-independent translation sequences in human and viral genomes. Science. 351:aad49392016. View Article : Google Scholar : PubMed/NCBI | |
Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 9:654–659. 2007. View Article : Google Scholar : PubMed/NCBI | |
Janas T, Janas MM, Sapoń K and Janas T: Mechanisms of RNA loading into exosomes. FEBS Lett. 589:1391–1398. 2015. View Article : Google Scholar : PubMed/NCBI | |
Chen CY and Sarnow P: Initiation of protein synthesis by the eukaryotic translational apparatus on circular RNAs. Science. 268:415–417. 1995. View Article : Google Scholar : PubMed/NCBI | |
Xia X, Li X, Li F, Wu X, Zhang M, Zhou H, Huang N, Yang X, Xiao F, Liu D, et al: A novel tumor suppressor protein encoded by circular AKT3 RNA inhibits glioblastoma tumorigenicity by competing with active phosphoinositide-dependent kinase-1. Mol Cancer. 18:1312019. View Article : Google Scholar : PubMed/NCBI | |
Liang WC, Wong CW, Liang PP, Shi M, Cao Y, Rao ST, Tsui SK, Waye MM, Zhang Q, Fu WM and Zhang JF: Translation of the circular RNA circβ-catenin promotes liver cancer cell growth through activation of the Wnt pathway. Genome Biol. 20:842019. View Article : Google Scholar : PubMed/NCBI | |
Hellen CU and Sarnow P: Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev. 15:1593–1612. 2001. View Article : Google Scholar : PubMed/NCBI | |
Zheng X, Chen L, Zhou Y, Wang Q, Zheng Z, Xu B, Wu C, Zhou Q, Hu W, Wu C and Jiang J: A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling. Mol Cancer. 18:472019. View Article : Google Scholar : PubMed/NCBI | |
Yang Y, Gao X, Zhang M, Yan S, Sun C, Xiao F, Huang N, Yang X, Zhao K, Zhou H, et al: Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis. J Natl Cancer Inst. 110:304–315. 2018. View Article : Google Scholar : PubMed/NCBI | |
Legnini I, Di Timoteo G, Rossi F, Morlando M, Briganti F, Sthandier O, Fatica A, Santini T, Andronache A, Wade M, et al: Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol Cell. 66:22–37.e9. 2017. View Article : Google Scholar : PubMed/NCBI | |
Abe N, Hiroshima M, Maruyama H, Nakashima Y, Nakano Y, Matsuda A, Sako Y, Ito Y and Abe H: Rolling circle amplification in a prokaryotic translation system using small circular RNA. Angew Chem Int Ed Engl. 52:7004–7008. 2013. View Article : Google Scholar : PubMed/NCBI | |
Abe N, Matsumoto K, Nishihara M, Nakano Y, Shibata A, Maruyama H, Shuto S, Matsuda A, Yoshida M, Ito Y and Abe H: Rolling circle translation of circular RNA in living human cells. Sci Rep. 5:164352015. View Article : Google Scholar : PubMed/NCBI | |
Konieczny P, Stepniak-Konieczna E and Sobczak K: MBNL proteins and their target RNAs, interaction and splicing regulation. Nucleic Acids Res. 42:10873–10887. 2014. View Article : Google Scholar : PubMed/NCBI | |
Li Z, Huang C, Bao C, Chen L, Lin M, Wang X, Zhong G, Yu B, Hu W, Dai L, et al: Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 22:256–264. 2015. View Article : Google Scholar : PubMed/NCBI | |
Smid M, Wilting SM, Uhr K, Rodríguez-González FG, de Weerd V, Prager-Van der Smissen WJ, van der Vlugt-Daane M, van Galen A, Nik-Zainal S, Butler A, et al: The circular RNome of primary breast cancer. Genome Res. 29:356–366. 2019. View Article : Google Scholar : PubMed/NCBI | |
Ye F, Tang QL, Ma F, Cai L, Chen M, Ran XX, Wang XY and Jiang XF: Analysis of the circular RNA transcriptome in the grade 3 endometrial cancer. Cancer Manag Res. 11:6215–6227. 2019. View Article : Google Scholar : PubMed/NCBI | |
Chen BJ, Byrne FL, Takenaka K, Modesitt SC, Olzomer EM, Mills JD, Farrell R, Hoehn KL and Janitz M: Analysis of the circular RNA transcriptome in endometrial cancer. Oncotarget. 9:5786–5796. 2017. View Article : Google Scholar : PubMed/NCBI | |
Xu H, Gong Z, Shen Y, Fang Y and Zhong S: Circular RNA expression in extracellular vesicles isolated from serum of patients with endometrial cancer. Epigenomics. 10:187–197. 2018. View Article : Google Scholar : PubMed/NCBI | |
Shu L, Peng Y, Zhong L, Feng X, Qiao L and Yi Y: CircZNF124 regulates cell proliferation, leucine uptake, migration and invasion by miR-199b-5p/SLC7A5 pathway in endometrial cancer. Immun Inflamm Dis. 9:1291–1305. 2021. View Article : Google Scholar : PubMed/NCBI | |
Lee II, Maniar K, Lydon JP and Kim JJ: Akt regulates progesterone receptor B-dependent transcription and angiogenesis in endometrial cancer cells. Oncogene. 35:5191–5201. 2016. View Article : Google Scholar : PubMed/NCBI | |
Jia Y, Liu M and Wang S: CircRNA hsa_circRNA_0001776 inhibits proliferation and promotes apoptosis in endometrial cancer via downregulating LRIG2 by sponging miR-182. Cancer Cell Int. 20:4122020. View Article : Google Scholar : PubMed/NCBI | |
Fang X, Wang J, Chen L and Zhang X: circRNA circ_POLA2 increases microRNA-31 methylation to promote endometrial cancer cell proliferation. Oncol Lett. 22:7622021. View Article : Google Scholar : PubMed/NCBI | |
Liu Y, Chang Y and Cai Y: Circ_0067835 sponges miR-324-5p to induce HMGA1 expression in endometrial carcinoma cells. J Cell Mol Med. 24:13927–13937. 2020. View Article : Google Scholar : PubMed/NCBI | |
Hosios AM, Hecht VC, Danai LV, Johnson MO, Rathmell JC, Steinhauser ML, Manalis SR and Vander Heiden MG: Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells. Dev Cell. 36:540–549. 2016. View Article : Google Scholar : PubMed/NCBI | |
Wang Q and Holst J: L-type amino acid transport and cancer: Targeting the mTORC1 pathway to inhibit neoplasia. Am J Cancer Res. 5:1281–1294. 2015.PubMed/NCBI | |
Yang P, Yun K and Zhang R: CircRNA circ-ATAD1 is downregulated in endometrial cancer and suppresses cell invasion and migration by downregulating miR-10a through methylation. Mamm Genome. 32:488–494. 2021. View Article : Google Scholar : PubMed/NCBI | |
Ziyad S and Iruela-Arispe ML: Molecular mechanisms of tumor angiogenesis. Genes Cancer. 2:1085–1096. 2011. View Article : Google Scholar : PubMed/NCBI | |
Wang Y, Yin L and Sun X: CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway. J Exp Clin Cancer Res. 39:1692020. View Article : Google Scholar : PubMed/NCBI | |
Yuan J, Yin Z, Tao K, Wang G and Gao J: Function of insulin-like growth factor 1 receptor in cancer resistance to chemotherapy. Oncol Lett. 15:41–47. 2018.PubMed/NCBI | |
Li F, Cai Y, Deng S, Yang L, Liu N, Chang X, Jing L, Zhou Y and Li H: A peptide CORO1C-47aa encoded by the circular noncoding RNA circ-0000437 functions as a negative regulator in endometrium tumor angiogenesis. J Biol Chem. 297:1011822021. View Article : Google Scholar : PubMed/NCBI | |
Wu Q, Zhang W, Liu Y, Huang Y, Wu H and Ma C: Histone deacetylase 1 facilitates aerobic glycolysis and growth of endometrial cancer. Oncol Lett. 22:7212021. View Article : Google Scholar : PubMed/NCBI | |
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI | |
Helmlinger G, Sckell A, Dellian M, Forbes NS and Jain RK: Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clin Cancer Res. 8:1284–1291. 2002.PubMed/NCBI | |
Holmlund C, Nilsson J, Guo D, Starefeldt A, Golovleva I, Henriksson R and Hedman H: Characterization and tissue-specific expression of human LRIG2. Gene. 332:35–43. 2004. View Article : Google Scholar : PubMed/NCBI | |
Rodolakis A, Biliatis I, Morice P, Reed N, Mangler M, Kesic V and Denschlag D: European society of gynecological oncology task force for fertility preservation: clinical recommendations for fertility-sparing management in young endometrial cancer patients. Int J Gynecol Cancer. 25:1258–1265. 2015. View Article : Google Scholar : PubMed/NCBI | |
Chen M, Jin Y, Li Y, Bi Y, Shan Y and Pan L: Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer. Int J Gynaecol Obstet. 132:34–38. 2016. View Article : Google Scholar : PubMed/NCBI | |
Yuan S, Zheng P, Sun X, Zeng J, Cao W, Gao W, Wang Y and Wang L: Hsa_Circ_0001860 promotes Smad7 to enhance MPA resistance in endometrial cancer via miR-520h. Front Cell Dev Biol. 9:7381892021. View Article : Google Scholar : PubMed/NCBI | |
Pawlik TM and Keyomarsi K: Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 59:928–942. 2004. View Article : Google Scholar : PubMed/NCBI | |
Shinde A, Li R, Amini A, Chen YJ, Cristea M, Dellinger T, Wang W, Wakabayashi M, Beriwal S and Glaser S: Improved survival with adjuvant brachytherapy in stage IA endometrial cancer of unfavorable histology. Gynecol Oncol. 151:82–90. 2018. View Article : Google Scholar : PubMed/NCBI | |
Sorolla MA, Parisi E and Sorolla A: Determinants of sensitivity to radiotherapy in endometrial cancer. Cancers (Basel). 12:19062020. View Article : Google Scholar : PubMed/NCBI | |
Gu X, Shi Y, Dong M, Jiang L, Yang J and Liu Z: Exosomal transfer of tumor-associated macrophage-derived hsa_circ_0001610 reduces radiosensitivity in endometrial cancer. Cell Death Dis. 12:8182021. View Article : Google Scholar : PubMed/NCBI | |
Hasengaowa, Kodama J, Kusumoto T, Shinyo Y, Seki N, Nakamura K, Hongo A and Hiramatsu Y: Loss of basement membrane heparan sulfate expression is associated with tumor progression in endometrial cancer. Eur J Gynaecol Oncol. 26:403–406. 2005.PubMed/NCBI | |
Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J, Chen D, Gu J, He X and Huang S: Circular RNA is enriched and stable in exosomes: A promising biomarker for cancer diagnosis. Cell Res. 25:981–984. 2015. View Article : Google Scholar : PubMed/NCBI | |
Shi Y, Jia L and Wen H: Circ_0109046 promotes the progression of endometrial cancer via regulating miR-136/HMGA2 axis. Cancer Manag Res. 12:10993–11003. 2020. View Article : Google Scholar : PubMed/NCBI | |
Zong ZH, Liu Y, Chen S and Zhao Y: Circ_PUM1 promotes the development of endometrial cancer by targeting the miR-136/NOTCH3 pathway. J Cell Mol Med. 24:4127–4135. 2020. View Article : Google Scholar : PubMed/NCBI | |
Yasuda K, Hirohashi Y, Kuroda T, Takaya A, Kubo T, Kanaseki T, Tsukahara T, Hasegawa T, Saito T, Sato N and Torigoe T: MAPK13 is preferentially expressed in gynecological cancer stem cells and has a role in the tumor-initiation. Biochem Biophys Res Commun. 472:643–647. 2016. View Article : Google Scholar : PubMed/NCBI | |
Liu Y, Chang Y and Cai Y: circTNFRSF21, a newly identified circular RNA promotes endometrial carcinoma pathogenesis through regulating miR-1227-MAPK13/ATF2 axis. Aging (Albany NY). 12:6774–6792. 2020. View Article : Google Scholar : PubMed/NCBI | |
Wu W, Zhou J, Wu Y, Tang X and Zhu W: Overexpression of circRNA circFAT1 in endometrial cancer cells increases their stemness by upregulating miR-21 through methylation. Cancer Biother Radiopharm. Jul 27–2021.(Epub ahead of print). View Article : Google Scholar | |
Shi R, Zhang W, Zhang J, Yu Z, An L, Zhao R, Zhou X, Wang Z, Wei S and Wang H: CircESRP1 enhances metastasis and epithelial-mesenchymal transition in endometrial cancer via the miR-874-3p/CPEB4 axis. J Transl Med. 20:1392022. View Article : Google Scholar : PubMed/NCBI | |
Tan S, Xia L, Yi P, Han Y, Tang L, Pan Q, Tian Y, Rao S, Oyang L, Liang J, et al: Exosomal miRNAs in tumor microenvironment. J Exp Clin Cancer Res. 39:672020. View Article : Google Scholar : PubMed/NCBI | |
Lyssiotis CA and Kimmelman AC: Metabolic interactions in the tumor microenvironment. Trends Cell Biol. 27:863–875. 2017. View Article : Google Scholar : PubMed/NCBI | |
Guo J, Tong J and Zheng J: Circular RNAs: A promising biomarker for endometrial cancer. Cancer Manag Res. 13:1651–1665. 2021. View Article : Google Scholar : PubMed/NCBI | |
Shi Y, He R, Yang Y, He Y, Shao K, Zhan and Wei B: Circular RNAs: Novel biomarkers for cervical, ovarian and endometrial cancer (Review). Oncol Rep. 44:1787–1798. 2020.PubMed/NCBI | |
Zheng R, Zeng H, Zhang S, Chen T and Chen W: National estimates of cancer prevalence in China, 2011. Cancer Lett. 370:33–38. 2016. View Article : Google Scholar : PubMed/NCBI | |
Takenaka K, Chen BJ, Modesitt SC, Byrne FL, Hoehn KL and Janitz M: The emerging role of long non-coding RNAs in endometrial cancer. Cancer Genet. 209:445–455. 2016. View Article : Google Scholar : PubMed/NCBI |